Increased DYRK1A could have contradictory effects related to AD: an anti-inflammatory and protective effect [37–39] associated with low homocysteine levels in the periphery as well as a deleterious hyperphosphorylation of Tau protein in the brain [17, 40]. This evidence concerns the gene MAPT and Alzheimer disease.